Trial intelligence / Profile preview

Tadalafil for lower urinary tract symptoms in patients with ureteral stents

IRCT2013113015597N1Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tadalafil in Micturition disorder and ureteral stent-related symptoms (USRS), sponsored by Tabriz University of Medical Sciences. Started Dec 2013; status: completed.

02

Drugs

tadalafil
03

Conditions

Micturition disorderureteral stent-related symptoms (USRS)

Beyond the preview

Go deeper on IRCT2013113015597N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2013113015597N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call